Safety, Pharmacokinetics And Efficacy Of Rc48-Adc In A Phase I Study In Patients With Her2-Overexpression Advanced Solid Cancer.

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 24|浏览3
暂无评分
摘要
e16059Background: Trastuzumab combined with chemotherapy is the standard first-line regimen in HER2- overexpression advanced gastric cancer, and there is no established therapy in the second-line s...
更多
查看译文
关键词
Regimen,Trastuzumab,Chemotherapy,Pharmacokinetics,Oncology,Medicine,Advanced gastric cancer,In patient,Internal medicine,Phase i study,Solid cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要